Protective Role for Type 4 Metabotropic Glutamate Receptors against Ischemic Brain Damage
- 15 December 2010
- journal article
- Published by SAGE Publications in Journal of Cerebral Blood Flow & Metabolism
- Vol. 31 (4) , 1107-1118
Abstract
We examined the influence of type 4 metabotropic glutamate (mGlu4) receptors on ischemic brain damage using the permanent middle cerebral artery occlusion (MCAO) model in mice and the endothelin-1 (Et-1) model of transient focal ischemia in rats. Mice lacking mGlu4 receptors showed a 25% to 30% increase in infarct volume after MCAO as compared with wild-type littermates. In normal mice, systemic injection of the selective mGlu4 receptor enhancer, N-phenyl-7-(hydroxyimino)cyclopropa[b]chromen-1a-caboxamide (PHCCC; 10 mg/kg, subcutaneous, administered once 30 minutes before MCAO), reduced the extent of ischemic brain damage by 35% to 45%. The drug was inactive in mGlu4 receptor knockout mice. In the Et-1 model, PHCCC administered only once 20 minutes after ischemia reduced the infarct volume to a larger extent in the caudate/putamen than in the cerebral cortex. Ischemic rats treated with PHCCC showed a faster recovery of neuronal function, as shown by electrocorticographic recording and by a battery of specific tests, which assess sensorimotor deficits. These data indicate that activation of mGlu4 receptors limit the development of brain damage after permanent or transient focal ischemia. These findings are promising because selective mGlu4 receptor enhancers are under clinical development for the treatment of Parkinson's disease and other central nervous system disorders.Keywords
This publication has 38 references indexed in Scilit:
- DAPK1 Interaction with NMDA Receptor NR2B Subunits Mediates Brain Damage in StrokeCell, 2010
- Induction of the Wnt Antagonist, Dickkopf-1, Contributes to the Development of Neuronal Death in Models of Brain Focal IschemiaJournal of Cerebral Blood Flow & Metabolism, 2008
- mGlu4 potentiation of K2P2.1 is dependant on C-terminal dephosphorylationMolecular and Cellular Neuroscience, 2008
- Synaptic and Extrasynaptic NMDA Receptor NR2 Subunits in Cultured Hippocampal NeuronsJournal of Neurophysiology, 2006
- Regulation of transmitter release by high-affinity group III mGluRs in the supraoptic nucleus of the rat hypothalamusNeuropharmacology, 2004
- Subtype-specific Expression of Group III Metabotropic Glutamate Receptors and Ca2+ Channels in Single Nerve TerminalsJournal of Biological Chemistry, 2002
- Metabotropic glutamate 1 (mGlu1) receptor antagonists enhance GABAergic neurotransmission: a mechanism for the attenuation of post-ischemic injury and epileptiform activity?Neuropharmacology, 2002
- Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathwaysNature Neuroscience, 2002
- Changes in Metabotropic Glutamate Receptor mRNA Levels Following Global Ischemia: Increase of a Putative Presynaptic Subtype (mGluR4) in Highly Vulnerable Rat Brain AreasJournal of Neurochemistry, 1994
- Changes in mRNA for metabotropic glutamate receptors after transient cerebral ischaemiaNeuroReport, 1994